Skip to content

The efficacy of tropical Andrographis paniculata extract in treatment of pruritus in chronic liver disease: A randomized, placebo-controlled study

The efficacy of tropical Andrographis paniculata extract in treatment of pruritus in chronic liver disease: A randomized, placebo-controlled study

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20250206011
Enrollment
44
Registered
2025-02-06
Start date
2021-01-27
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patient with chonic liver disease who suffered with pruritus for more than 2 weeks with out known underlying specific skin disease such as atopic dermatitis, psoriasis, dermatophytosis, candidiasis, or other active skin infection. Pruritius, chronic liver disease, cirrhosis, Andrographis paniculata, Herbal medicine

Interventions

Participants underwent a computer generated 1:1 block randomization to receive either a 4% Andrographis paniculata extract cream (supplied by SBU Corporation) or a placebo moisturizing cream. Applicat
Experimental Drug,Placebo Comparator Drug
tropical Andrographis paniculata extract group,Placebo ( moisterizing cream)

Sponsors

Chiang Rai Prachanukroh hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: The inclusion criteria for participants required 1. Individuals to be 18 years of age or older  2. Diagnosed with chronic liver disease or cholestatic liver disease 3. Presented with generalized pruritus persisting for more than 2 weeks.

Exclusion criteria

Exclusion criteria: The exclusion criteria included: 1. Allergy to Andrographis paniculata. 2. Use of topical steroids within the past 2 weeks. 3. Impaired consciousness due to specific conditions. 4. A life expectancy of less than 4 weeks. 5. Pregnancy or breastfeeding. 6. Blood pressure below 90/60 mmHg. 7. Low platelet counts or abnormal blood clotting. 8. Known underlying skin diseases such as atopic dermatitis, psoriasis, dermatophytosis, candidiasis, or other chronic skin infections

Design outcomes

Primary

MeasureTime frame
pruritus 4 weeks Dynamic pruritus score

Secondary

MeasureTime frame
Quality of life 4 week Dermatology Life Quality Index( DLQI)

Countries

Thailand

Contacts

Public ContactChotipong Siripipattanamongkol

Chiang Rai Prachanukroh hospital

dr.chotipong@gmail.com0816929910

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026